Clinical Validation and Prognostic Evaluation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Severe Aortic Valve Stenosis
- Sponsor
- Ignacio J. Amat Santos
- Enrollment
- 274
- Locations
- 15
- Primary Endpoint
- Degree of commissural alignment
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
Background: Transcatheter aortic valve replacement (TAVR) has become the preferred therapy for aortic stenosis. Given the growing life-expectancy, the risk of requiring coronary interventions or of developing prosthesis degeneration that could require TAVR-in-TAVR for its treatment progressively increases. During standard TAVI procedures the native and the prosthesis commissures are randomly aligned with misalignment in up to 70% of the cases. This might hinder coronary re-access in 18% of the cases, increase the risk of coronary obstruction during future TAVR-in-TAVR procedures, and has been associated to greater residual gradients.
Methods: Although several techniques have been developed to increase the degree of commissural alignment, all are imperfect or imply manipulation of the system within the patient, potentially increasing the risk of complications. The research team developed a software based on computed tomography analysis that allows planification of accurate commissural alignment by inserting the delivery system in a patient-specific degree of rotation.
Aim: The proponent team aimed to prospectively validate this methodology comparing a cohort of patients harboring TAVR with Acurate Commissural Alignment (ACA) vs. a control cohort with non-ACA standard technique, in order to determine benefits in terms of coronary re-access and clinical events (coronary events, valve degeneration, and TAVR-in-TAVR).
Investigators
Ignacio J. Amat Santos
Coordinator of Interventional Cardiology Unit
Hospital Clínico Universitario de Valladolid
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with severe aortic stenosis admitted to TAVR by Heart Team
- •Pre-procedure CT-Scan for planning available.
- •Signed informed consent.
Exclusion Criteria
- •Allergic to contrast
- •Severe renal failure (GFR \< 30 mL/min)
- •Indication for chronic anticoagulation
- •Horizontal aorta and/or severe aortic tortuosity
Outcomes
Primary Outcomes
Degree of commissural alignment
Time Frame: 6 months
Mean minimum angular deviation between TAVR posts and aortic valve commissures measured in CT-scan
Successful coronary re-access
Time Frame: 10 minutes, right after TAVR
Coronary re-access was successful or not after TAVR implant
Presence of leaflet thrombosis
Time Frame: 6 months
Presence of clinical/subclinical leaflets thrombosis assessed by CT-Scan
Secondary Outcomes
- Residual transvalvular gradients(24 months)